NALOXONE HYDROCHLORIDE SR GASTRO-RESISTANT SUSTAINED RELEASE CAPSULES AS A TREATMENT FOR FUNCTIONAL CONSTIPATION: A RANDOMISED, DOUBLE BLIND CONTROLLED TRIAL IN SECONDARY CARE

Registry ID

EUCTR2009-011853-42

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

Norfolk and Norwich University Hospital NHS Trust

Start date

2009-12-22

Completion date

2012-01-30

Last update

2026-08-16

Conditions

• Functional constipation

Summary

The primary objective of this study is to assess the efficacy of nalcol (number of responders) when used as an adjunct to usual laxatives in the treatment of patients with refractory constipation as compared to a placebo group (i.e. Period 2).

Locations

• , , UK

View on source registry